top of page
  • Writer's pictureAMECO

Ultrasound for COVID-19 patients

Updated: Jun 24, 2020

The COVID-19 pandemic continues to develop rapidly, particularly in the United States and Europe. Imaging procedures are an essential component of care for patients with symptoms. Besides computed tomography (CT) and X-ray imaging, lung ultrasound (LUS) has become an emerging tool for assessing COVID-19 patients.

The clinical spectrum of COVID-19 ranges from mild respiratory complaints to severe lung failure. A rapid and reliable distinction has to be made between SARS-CoV-2-related pneumonia and other lung conditions. COVID-19 is primarily diagnosed on the basis of a real-time polymerase chain reaction (RT-PCR) assay of throat swabs or sputum [1]. On suspicion of COVID-19, existing CT or X-ray imaging is standard. But where emergency rooms and intensive care units are already confronted with COVID-19 patients or are preparing for a sharp increase, LUS is gaining importance – particularly as it is predestined to be used at the bedside in the form of point-of-care ultrasound (PoCUS).

Characteristics of COVID-19 that can be visualized with LUS

SARS-CoV-2 infections primarily affect the smallest alveoli at the periphery of the lung. As a rule the lesions are located close to the pleura and thus in an area that can be visualized very well by ultrasound. In LUS, diagnosis is based on artifacts – which are apparent, interfering phenomena in the X-ray, CT or MRT image. For COVID-19, the following characteristic artifacts have been found [2, 3]: 

  • The echo-rich horizontal line corresponding to the visceral pleura (pleura line) appears thickened and irregular

  • B-lines with varying patterns, including focal, multifocal, and confluent lines

  • Consolidation (accumulations of fluid and/or tissue in pulmonary alveoli preventing gas exchange) with varied patterns, including small multifocal, non-translobar and translobar lines

  • Appearance of A-lines during the recovery phase

  • Pleural effusions are rare

The relevant studies are rather small, with only 20 patients. However, the group around Qian-Yi Peng [2] comes to the conclusion that the sonographic findings are comparable with those of lung CT (table).


bottom of page